
IDEAYA Biosciences Inc an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including dire... IDEAYA Biosciences Inc an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.55 | -2.93176972281 | 18.76 | 19.59 | 18.12 | 868261 | 18.73127455 | CS |
4 | -2.08 | -10.2513553475 | 20.29 | 22.42 | 16.95 | 871538 | 19.64293238 | CS |
12 | -6.88 | -27.4212833798 | 25.09 | 26.44 | 16.95 | 857318 | 22.05481917 | CS |
26 | -16.93 | -48.1787137166 | 35.14 | 36.7 | 16.95 | 910470 | 26.04680135 | CS |
52 | -25.14 | -57.9930795848 | 43.35 | 46.4 | 16.95 | 843592 | 32.26206701 | CS |
156 | 5.49 | 43.1603773585 | 12.72 | 47.735 | 8.14 | 666997 | 27.82830576 | CS |
260 | 14.71 | 420.285714286 | 3.5 | 47.735 | 3.2 | 496492 | 25.82260742 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales